Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in cancer therapy

Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in cancer therapy

US Patent 6040334 · Granted Mar 21, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Hsp90 inhibitors and uses thereof2022
Thiohydantoin derivatives and uses thereof2018
Indazole derivatives and uses thereof2017
HSF1 as a marker in tumor prognosis and treatment2017
Compounds for treating infectious diseases2016
Pharmacodynamic assays2016
Marker for predicting gastric cancer prognosis and method for predicting gastric2016
Novobiocin analogues as anticancer agents2010
Novobiocin analogues as anticancer agents2009
Protector for wrist watch lens or the like2000
Inhibition of protein kinase activity by aptameric action of oligonucleotides1999
Protector for wrist watch lens1999